Clinical, general, hemocoagulation and pathologicanatomical features of patients with moderate and severe community acquired pneumonia by the data of retrospective analysis.
DOI:
https://doi.org/10.26641/2307-0404.2017.3.111858Keywords:
community acquired pneumonia, complications, thrombosisAbstract
According to literature data,patients with community acquired pneumonia (CAP) fall into several groups of unfavorable prognostic factors. Development of thrombotic complications is one of causes of mortality of hospitalized patients. In this case systemic inflammation, which is always present inmoderate and severe CAP, is the starting mechanism of formation of disorders in the hemostasis system. The aim of our work was to determine anamnestic, clinical, laboratory and pathologic anatomical features in patients with CAP, taking into account markers of systemic inflammation and coagulogram indices, as well as predicting the occurrence of complications. In the course of the work, a retrospective analysis of 151 medical histories of hospitalized patients with CAP was made. We analyzed anthropometric indicators, complaints at the time of hospitalization, results of physical examination, results of the chest X-ray, clinical and laboratory indicators, microbiological sputum analysis and to assess the possibility of thrombotic complications a RAM scale was used. It was found that late asking for medical help, the presence of mixed infection, underestimation of the severity of condition and severe systemic inflammation increase the risk of lethal outcome in patients with CAP. Considering a high risk of thrombosis in patients with CAP, it is necessary to assess the risk of thrombotic complications with the help of special scales, as well as timely detection and correction of disorders from the hemostasis system.
References
Dzyublyk AYa, Judyna LV [Basic principles of diagnosis and treatment of community-acquired pneumonia]. Zdorov"ya Ukrayiny. 2011;6:47-50. Ukrainian.
Lapach SN, Gubenko AV, Babych PN. [Statistical methods in biomedical research using Exel]. Moryon, 2000;320. Russian.
Feshchenko YuI, Holubovs'ka OA, Honcharov KA, Dzyublyk OYa. [Community acquired pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antibiotic therapy (project of clinical guidelines)]. Ukrayins'kyy pul'monolohichnyy zhurnal, 2012;4:5-17. Ukrainian.
Pertseva TO, Kireyeva TV, Bielosludtseva КO. [Retrospective analysis of lethal cases of severe hostile pneumonia: "Masks of Severe Pneumonia"]. Ukrayins'kyy pul'monolohichnyy zhurnal, 2013;2:26–30, Ukrainian.
Pertseva TO, Kiryeyeva TV, Bielosludtseva KO, Boltyans'kyy SV. [Severe virus-associated hospitalized pneumonia: predictors of lethality]. Zaporozhskyy medytsynskyy zhurnal, 2016;3(96):38–45. Ukrainian.
[Comparative data on the prevalence of respiratory diseases and medical care for patients with pulmonologic and allergic diseases inUkrainefor 2006-2012]. Natsional'na akademiya medychnykh nauk Ukrayiny. Tsentr medychnoyi statystyky Ukrayiny MOZ Ukrayiny, 2013;2-4. Ukrainian.
[About the approval of clinical protocols for the provision of medical care in the specialty "Pulmonology"]. Order N 128 MoH ofUkraine; 2007. Ukrainian.
Birnbaumer DM. SMART-COP: A Better Pneumonia Stratification Score? Journal Watch Emergency Medicine. 2008;1:375.
Sachin Y, D'Angelo G, Mayr Fl, Kellum JA. Elevated Hemostasis Markers after Pneumonia Increases One-Year Risk of All-Cause and Cardiovascular Deaths The GenIMS Investigator Published; 2011.
Singanayagam A, Singanayagam A, Elder DHJ, Chalmers JD. Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Eur. resp. j. 2012;39(1):187-96.
Maris NA, De Vos AF, Bresser P. Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb. Haemost. 2005;93(1036):40.
Zakai N, Wright J, Cushman M. Risk factors for venous thromboembolism among hospitalized patients. Journal of Thrombosis and Haemostasis. 2004;2156-61.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2017 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
